ROSGQ — Rosetta Genomics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics
Brief: Rosetta Genomics Announces Results From Extraordinary Meeting Of Shareholders To Vote On Proposed Merger With Genoptix
Brief: Rosetta Genomics suspends 2017 revenue and unit guidance for Reveal
Brief: Rosetta Genomics prices public offering of 1.95 mln units at $1.40/unit
Brief: Rosetta Genomics announces 1-for-12 reverse stock split
Brief: Rosetta Genomics reports preliminary Q4 rosettagx reveal results
Brief: Rosetta Genomics announces U.S. patent allowances for two RosettaGX RevealTM MicroRNAs
Brief: Rosetta Genomics files for resale of up to 15.5 mln of co's ordinary shares by selling stockholders
Brief: Rosetta Genomics announces pricing of $5 million concurrent registered direct and private placement offering
Brief: Rosetta Genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients
stopped testing of four of its pcr-based gene mutation assays
Brief: Rosetta Genomics fortifies intellectual property portfolio with two new patent allowances
Brief: Rosetta Genomics enters distribution agreement for RosettaGX Reveal in Israel with Rhenium
Brief: Rosetta Genomics Q2 non-gaap loss per share $0.15 excluding items
Brief: Rosetta Genomics gets notice of rescission of conditional approval from New York State Department of Health for 4 of co's Allele-specific PCR-based assays
Brief: Rosetta Genomics inks new agreement with Galaxy Health Network